以淋巴细胞为导向的免疫调节可缓解胆瘤相关的自身免疫性肺炎
Elise M N Ferré1, Diana X Nichols-Vinueza1, Lindsey B Rosen1
1Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Journal of clinical immunology
|July 2, 2024
概括
这项研究表明,淋巴细胞导向免疫调节有效地治疗了两个胸腺瘤患者的自身免疫性肺炎,从而导致持续的缓解. 这种方法为瘤相关的呼吸道疾病提供了有前途的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
背景情况:
- 胸腺瘤与自身免疫性疾病和自身免疫调节剂 (AIRE) 缺乏有关.
- 与胸腺瘤相关的自身免疫性肺炎与APECED等遗传性AIRE缺陷综合征具有共同特征.
- 这突显了与胸腺瘤相关的肺部疾病中潜在的自身免疫成分.
研究的目的:
- 为了研究淋巴细胞导向免疫调节对瘤相关肺炎的疗效.
- 为了评估活检证明的胸腺瘤和肺炎患者的治疗结果.
主要方法:
- 两个患有肺炎的胸腺瘤患者接受了淋巴细胞导向免疫调节 (阿扎西奥普林+/- 利图西马布).
- 综合评估包括临床,实验室,放射和肺功能测试.
- 在治疗前和治疗后测量了肺特异性自身抗体 (KCNRG,BPIFB1).
主要成果:
- 结合T和B淋巴细胞免疫调节改善了临床,功能和放射性参数.
- 这两位患者在治疗后12-36个月内实现了持续缓解.
- 在6个月的随访后,观察到显著改善.
结论:
- 淋巴细胞导向免疫调节成功地缓解了瘤患者的自身免疫性肺炎.
- 这种治疗策略对管理瘤相关的自身免疫性肺部疾病充满希望.
相关概念视频
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Cell-mediated Immune Responses
68.1K
Overview
68.1K
T Cell Types and Functions
998
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
998


